Skip to main content

Calciphylaxis

  • Chapter
  • First Online:
Skin Necrosis

Abstract

The complete physiopathology is still unclear. Two separate processes have been described: a progressive calcification of medium and small vessels of the subcutaneous and fat tissues related to an abnormal phosphate/calcium ratio occurring in the presence of predisposing factors (chronic vasculopathy, diabetes mellitus, obesity, renal insufficiency, etc.) and an acute phase caused by a decreased blood flow (hypotension, hemostatis perturbations and coagulopathy, infection, injury, etc.) causing the infarction of the tissues. The main risk factor for calciphylaxis is the chronic renal insufficiency with or without a hyperparathyroidy. It mostly occurs on a dialysed patient but may be also associated with other conditions (corticosteroids or antivitamin K therapy, neoplasia, chronic inflammation, etc.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Banerjee C, Woller SC, Holm JR, Stevens SM, Lahey MJ. Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy. Clin Appl Thromb Hemost. 2010;16(3):345–50.

    Article  PubMed  Google Scholar 

  2. Bechara FG, Altmeyer P, Kreuter A. Should we perform surgical debridement in calciphylaxis? Dermatol Surg. 2009;35(3):554–5.

    Article  CAS  PubMed  Google Scholar 

  3. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. Calciphylaxis in dialysis patients. Néphrologie et thérapeutique. 2010;6:499–504.

    Article  PubMed  Google Scholar 

  4. Weenig RH. Pathogenesis of calciphylaxis. J Am Acad Dermatol. 2008;58(3):458–71.

    Article  PubMed  Google Scholar 

  5. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569–79.

    Article  PubMed  Google Scholar 

  6. Salmhofer H, Franzen M, Hitzl W, Koller J, Kreymann B, Fend F, Hauser-Kronberger C, Heemann U, Berr F, Schmaderer C. Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Kidney Blood Press Res. 2013;37(4–5):346–59. http://www.ncbi.nlm.nih.gov/pubmed/24247072.

  7. Djahny Gauthey, Jérôme Morisod, Martial Coutaz.Calcyphylaxie.Rev. Med. Suisse 2008;4:1167–1171.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Véronique del Marmol .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Wien

About this chapter

Cite this chapter

Benhadou, F., del Marmol, V. (2015). Calciphylaxis. In: Téot, L., Meaume, S., Akita, S., Ennis, W.J., del Marmol, V. (eds) Skin Necrosis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1241-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1241-0_25

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1240-3

  • Online ISBN: 978-3-7091-1241-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics